Fingolimod induces neurogenesis in adult mouse hippocampus and improves contextual fear memory

Translational Psychiatry

Volumn 5, Issue 11, 2015, Pages

  Efstathopoulos, P ^a,b   Kourgiantaki, A ^a,b   Karali, K ^a,b   Sidiropoulou, K ^c   Margioris, A N ^a   Gravanis, A ^a,b   Charalampopoulos, I ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b INSTITUTE OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY   (Greece)

^c UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

FINGOLIMOD; SPHINGOSINE 1 PHOSPHATE RECEPTOR; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DENTATE GYRUS; FEAR; FEAR CONDITIONING TEST; HIPPOCAMPUS; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; MALE; MEMORY; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; STEM CELL CULTURE; ANIMAL; C57BL MOUSE; DRUG EFFECTS;

ANIMALS; FEAR; FINGOLIMOD HYDROCHLORIDE; HIPPOCAMPUS; IMMUNOSUPPRESSIVE AGENTS; MALE; MEMORY; MICE; MICE, INBRED C57BL; NEUROGENESIS;

EID: 84978402859     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2015.179     Document Type: Article

References (45)

1. Deng W, Aimone JB, Gage FH. New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory? Nat Rev Neurosci 2010; 11: 339-350.
2. Aimone JB, Deng W, Gage FH. Adult neurogenesis: integrating theories and separating functions. Trends Cogn Sci 2010; 14: 325-337.
3. Zhao C, Deng W, Gage FH. Mechanisms and functional implications of adult neurogenesis. Cell 2008; 132: 645-660.
4. Kuhn HG, Dickinson-Anson H, Gage FH. Neurogenesis in the dentate gyrus of the adult rat: Age-related decrease of neuronal progenitor proliferation. J Neurosci 1996; 16: 2027-2033.
5. Bouab M, Paliouras GN, Aumont A, Forest-Berard K, Fernandes KJ. Aging of the subventricular zone neural stem cell niche: Evidence for quiescence-associated changes between early and mid-adulthood. Neuroscience 2011; 173: 135-149.
6. Gomez-Nicola D, Suzzi S, Vargas-Caballero M, Fransen NL, Al-Malki H, Cebrian-Silla A et al. Temporal dynamics of hippocampal neurogenesis in chronic neurodegeneration. Brain 2014; 137: 2312-2328.
7. Sicotte NL, Kern KC, Giesser BS, Arshanapalli A, Schultz A, Montag M et al. Regional hippocampal atrophy in multiple sclerosis. Brain 2008; 131: 1134-1141.
8. Brinkmann V, Billich A, Baumruker T, Heining P, Schmouder R, Francis G et al. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov 2010; 9: 883-897.
9. Choi JW, Chun J. Lysophospholipids and their receptors in the central nervous system. Biochim Biophys Acta 2013; 1831: 20-32.
10. Groves A, Kihara Y, Chun J. Fingolimod: direct CNS effects of sphingosine 1- phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy. J Neurol Sci 2013; 328: 9-18.
11. Brunkhorst R, Vutukuri R, Pfeilschifter W. Fingolimod for the treatment of neurological diseases-state of play and future perspectives. Front Cell Neurosci 2014; 8: 283.
12. Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004; 427: 355-360.
13. Coelho RP, Payne SG, Bittman R, Spiegel S, Sato-Bigbee C. The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors. J Pharmacol Exp Ther 2007; 323: 626-635.
14. Miron VE, Jung CG, Kim HJ, Kennedy TE, Soliven B, Antel JP. FTY720 modulates human oligodendrocyte progenitor process extension and survival. Ann Neurol 2008; 63: 61-71.
15. McGiffert C, Contos JJ, Friedman B, Chun J. Embryonic brain expression analysis of lysophospholipid receptor genes suggests roles for s1p(1) in neurogenesis and s1p(1-3) in angiogenesis. FEBS Lett 2002; 531: 103-108.
16. Harada J, Foley M, Moskowitz MA, Waeber C. Sphingosine-1-phosphate induces proliferation and morphological changes of neural progenitor cells. J Neurochem 2004; 88: 1026-1039.
17. Mizugishi K, Yamashita T, Olivera A, Miller GF, Spiegel S, Proia RL. Essential role for sphingosine kinases in neural and vascular development. Mol Cell Biol 2005; 25: 11113-11121.
18. Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000; 20: 9104-9110.
19. Rossi C, Angelucci A, Costantin L, Braschi C, Mazzantini M, Babbini F et al. Brainderived neurotrophic factor (BDNF) is required for the enhancement of hippocampal neurogenesis following environmental enrichment. Eur J Neurosci 2006; 24: 1850-1856.
20. Drew MR, Denny CA, Hen R. Arrest of adult hippocampal neurogenesis in mice impairs single- but not multiple-trial contextual fear conditioning. Behav Neurosci 2010; 124: 446-454.
21. Ortega-Martinez S, Trejo JL. The postnatal origin of adult neural stem cells and the effects of glucocorticoids on their genesis. Behav Brain Res 2015; 279: 166-176.
22. Deogracias R, Yazdani M, Dekkers MP, Guy J, Ionescu MC, Vogt KE et al. Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome. Proc Natl Acad Sci USA 2012; 109: 14230-14235.
23. Lu P, Jones LL, Snyder EY, Tuszynski MH. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 2003; 181: 115-129.
24. Barnabe-Heider F, Miller FD. Endogenously produced neurotrophins regulate survival and differentiation of cortical progenitors via distinct signaling pathways. J Neurosci 2003; 23: 5149-5160.
25. Sahay A, Scobie KN, Hill AS, O'Carroll CM, Kheirbek MA, Burghardt NS et al. Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation. Nature 2011; 472: 466-470.
26. Codega P, Silva-Vargas V, Paul A, Maldonado-Soto AR, Deleo AM, Pastrana E et al. Prospective identification and purification of quiescent adult neural stem cells from their in vivo niche. Neuron 2014; 82: 545-559.
27. Payne SG, Milstien S, Spiegel S. Sphingosine-1-phosphate: dual messenger functions. FEBS Lett 2002; 531: 54-57.
28. Osinde M, Mullershausen F, Dev KK. Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors. Neuropharmacology 2007; 52: 1210-1218.
29. Lee J, Duan W, Mattson MP. Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J Neurochem 2002; 82: 1367-1375.
30. Shetty AK, Turner DA. In vitro survival and differentiation of neurons derived from epidermal growth factor-responsive postnatal hippocampal stem cells: inducing effects of brain-derived neurotrophic factor. J Neurobiol 1998; 35: 395-425.
31. Hait NC, Allegood J, Maceyka M, Strub GM, Harikumar KB, Singh SK et al. Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 2009; 325: 1254-1257.
32. Hait NC, Wise LE, Allegood JC, O'Brien M, Avni D, Reeves TM et al. Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory. Nat Neurosci 2014; 17: 971-980.
33. Saxe MD, Battaglia F, Wang JW, Malleret G, David DJ, Monckton JE et al. Ablation of hippocampal neurogenesis impairs contextual fear conditioning and synaptic plasticity in the dentate gyrus. Proc Natl Acad Sci USA 2006; 103: 17501-17506.
34. Kheirbek MA, Klemenhagen KC, Sahay A, Hen R. Neurogenesis and generalization: A new approach to stratify and treat anxiety disorders. Nat Neurosci 2012; 15: 1613-1620.
35. Nuzzo LD, Orlando R, Tognoli C, Di Pietro P, Bertini G, Miele J et al. Antidepressant activity of fingolimod in mice. Pharmacol Res Perspect 2015; 3: E00135.
36. Giannakopoulou A, Grigoriadis N, Bekiari C, Lourbopoulos A, Dori I, Tsingotjidou AS et al. Acute inflammation alters adult hippocampal neurogenesis in a multiple sclerosis mouse model. J Neurosci Res 2013; 91: 890-900.
37. Huehnchen P, Prozorovski T, Klaissle P, Lesemann A, Ingwersen J, Wolf SA et al. Modulation of adult hippocampal neurogenesis during myelin-directed autoimmune neuroinflammation. Glia 2011; 59: 132-142.
38. Chang A, Smith MC, Yin X, Fox RJ, Staugaitis SM, Trapp BD. Neurogenesis in the chronic lesions of multiple sclerosis. Brain 2008; 131: 2366-2375.
39. Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008; 7: 1139-1151.
40. Thornton AE, Raz N, Tucke KA. Memory in multiple sclerosis: contextual encoding deficits. J Int Neuropsychol Soc 2002; 8: 395-409.
41. Czerniawski J, Guzowski JF. Acute neuroinflammation impairs context discrimination memory and disrupts pattern separation processes in hippocampus. J Neurosci 2014; 34: 12470-12480.
42. Siegert RJ, Abernethy DA. Depression in multiple sclerosis: A review. J Neurol Neurosurg Psychiatry 2005; 76: 469-475.
43. Asle-Rousta M, Kolahdooz Z, Oryan S, Ahmadiani A, Dargahi L. FTY720 (fingolimod) attenuates beta-amyloid peptide (Abeta42)-induced impairment of spatial learning and memory in rats. J Mol Neurosci 2013; 50: 524-532.
44. Omidbakhsh R, Rajabli B, Nasoohi S, Khallaghi B, Mohamed Z, Naidu M et al. Fingolimod affects gene expression profile associated with LPS-induced memory impairment. Exp Brain Res 2014; 232: 3687-3696.
45. Fukumoto K, Mizoguchi H, Takeuchi H, Horiuchi H, Kawanokuchi J, Jin S et al. Fingolimod increases brain-derived neurotrophic factor levels and ameliorates amyloid beta-induced memory impairment. Behav Brain Res 2014; 268: 88-93.